Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma-Reference-Cited by-同舟云学术

Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma

Published:2023-09-05 Issue:1 Volume:13 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Qiang Wanting,Jin Lina,Luo Tiancheng,Jia Yanchun,Lu Jing,Liu Jin,He Haiyan,Qian Ziliang,Mithraprabhu Sridurga^ORCID,Liang Yang^ORCID,Gale Robert Peter,Tao Xia,Wu Depei,Du Juan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

https://www.nature.com/articles/s41408-023-00904-9.pdf

Reference15 articles.

1. Caers J, Garderet L, Kortum KM, O’Dwyer ME, van de Donk N, Binder M, et al. European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica. 2018;103:1772–84.

2. Costa LJ, Derman BA, Bal S, Sidana S, Chhabra S, Silbermann R, et al. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia. 2021;35:18–30.

3. Lahuerta JJ, Paiva B, Vidriales MB, Cordon L, Cedena MT, Puig N, et al. Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials. J Clin Oncol. 2017;35:2900–10.

4. Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, Garcia-Sanchez O, Bottcher S, et al. Next generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31:2094–103.

5. Moreau P, Zamagni E. MRD in multiple myeloma: more questions than answers. Blood Cancer J. 2017;7:639.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09